PubMed

Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation.

Cattan N, Saison-Behmoaras T, Mari B, Mazeau C, Amiel JL, Rossi B, Gioanni J.

Oncol Rep. 2000 May-Jun;7(3):497-500.PMID: 10767358 [PubMed - indexed for MEDLINE]Related articles

A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.

Hong SJ, Lee T, Park YS, Lee KO, Chung BH, Lee SH.

Yonsei Med J. 1996 Dec;37(6):371-9.PMID: 9048488 [PubMed - indexed for MEDLINE]Related articlesFree article

Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.

Knowles MA, Williamson M.

Cancer Res. 1993 Jan 1;53(1):133-9.PMID: 8093230 [PubMed - indexed for MEDLINE]Related articlesFree article

c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.

Weismanová E, Kalúz S, Skorvaga M.

Neoplasma. 1993;40(4):223-7.PMID: 7903794 [PubMed - indexed for MEDLINE]Related articles

Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.

Czerniak B, Cohen GL, Etkind P, Deitch D, Simmons H, Herz F, Koss LG.

Hum Pathol. 1992 Nov;23(11):1199-204.PMID: 1427748 [PubMed - indexed for MEDLINE]Related articles

Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.

Masui T, Mann AM, Garland EM, Okamura T, Johansson PL, Cohen SM.

Mol Carcinog. 1990;3(4):210-5.PMID: 2206284 [PubMed - indexed for MEDLINE]Related articles

Screening of human bladder tumors and urine sediments for the presence of H-ras mutations.

Levesque P, Ramchurren N, Saini K, Joyce A, Libertino J, Summerhayes IC.

Int J Cancer. 1993 Nov 11;55(5):785-90.PMID: 7902340 [PubMed - indexed for MEDLINE]Related articles

Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.

Bouras M, Parvaz P, Berger N, Paulin C, Revol A.

Ann Biol Clin (Paris). 1995;53(10-11):549-55.PMID: 8787281 [PubMed - indexed for MEDLINE]Related articles

Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.

Grimmond SM, Raghavan D, Russell PJ.

Urol Res. 1992;20(2):121-6.PMID: 1553789 [PubMed - indexed for MEDLINE]Related articles

Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.

Weise B, Ghebremedhin E, Zschunke F, Radzun HJ.

Gen Diagn Pathol. 1996 Jun;142(1):45-52.PMID: 8793486 [PubMed - indexed for MEDLINE]Related articles

Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.

Masui T, Mann AM, Borgeson CD, Garland EM, Okamura T, Fujii H, Pelling JC, Cohen SM.

Teratog Carcinog Mutagen. 1993;13(5):225-33.PMID: 7905676 [PubMed - indexed for MEDLINE]Related articles

Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.

Saito S, Hata M, Fukuyama R, Sakai K, Kudoh J, Tazaki H, Shimizu N.

Int J Urol. 1997 Mar;4(2):178-85.PMID: 9179693 [PubMed - indexed for MEDLINE]Related articles

Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.

Burchill SA, Neal DE, Lunec J.

Br J Urol. 1994 May;73(5):516-21.PMID: 8012773 [PubMed - indexed for MEDLINE]Related articles

A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.

Nishikawa T, Maemura K, Hirata I, Matsuse R, Morikawa H, Toshina K, Murano M, Hashimoto K, Nakagawa Y, Saitoh O, Uchida K, Katsu K.

Clin Chim Acta. 2002 Apr;318(1-2):107-12.PMID: 11880119 [PubMed - indexed for MEDLINE]Related articles

Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer.

Campbell C, Quinn AG, Rees JL.

Br J Dermatol. 1993 Feb;128(2):111-4.PMID: 8096149 [PubMed - indexed for MEDLINE]Related articles

Incidence and effects of Ha-ras codon 12 G-->A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus.

Liston BW, Gupta A, Nines R, Carlton PS, Kresty LA, Harris GK, Stoner GD.

Mol Carcinog. 2001 Sep;32(1):1-8.PMID: 11568970 [PubMed - indexed for MEDLINE]Related articles

Mutations of RAS gene family in specimens of bladder cancer.

Karimianpour N, Mousavi-Shafaei P, Ziaee AA, Akbari MT, Pourmand G, Abedi A, Ahmadi A, Afshin Alavi H.

Urol J. 2008 Fall;5(4):237-42.PMID: 19101897 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of RAS oncogene mutation in head and neck carcinomas.

Anderson JA, Irish JC, Ngan BY.

J Otolaryngol. 1992 Oct;21(5):321-6.PMID: 1361585 [PubMed - indexed for MEDLINE]Related articles

Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.

Olderøy G, Daehlin L, Ogreid D.

Anticancer Res. 1998 Jul-Aug;18(4A):2675-8.PMID: 9703927 [PubMed - indexed for MEDLINE]Related articles

Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.

Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H.

Carcinogenesis. 2000 Jul;21(7):1391-6.PMID: 10874018 [PubMed - indexed for MEDLINE]Related articlesFree article